DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Positive impactOrders & Deals

Viyash Scientific Limited — Acquisition

NSE 1 hr ago·1 Oct 2026, 12:27 pm

Viyash Scientific

Viyash Scientific Limited has completed the acquisition of BioForLife Italia S.r.l, a company based in Italy. This strategic move expands Viyash's global footprint and strengthens its manufacturing capabilities in the medical device sector.

For investors, this development is significant as it signals the company's intent to grow beyond its domestic market. By integrating BioForLife's operations, Viyash aims to enhance its product portfolio and operational efficiency, which could positively impact its long-term financial performance.

Moving forward, investors should monitor the integration progress and any updates on cost synergies. It will also be important to watch for detailed financial disclosures regarding the acquisition's impact on Viyash's earnings and balance sheet.

Affected stocks

Bullish1 stock

Viyash Scientific

VIYASH Bullish

₹235.80

Bull / bear label is derived from the article's AI sentiment — indicative, not advice. Prices may be delayed.

Key takeaways

Concerns Viyash Scientific (VIYASH).
Category: Orders & Deals.
AI reads the tone as positive (potentially bullish) for the stock.

Why it matters

A routine update for Viyash Scientific. The tone is positive — historically associated with upward pressure, though not predictive. Use the price and stock snapshot to gauge how the market is responding.

Summary & analysis by DocStoX. Full story at NSE.